| 1 |
33863898 | Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome. | 2021 Apr 16 |
2 |
| 2 |
34592881 | Berberine inhibited carotid atherosclerosis through PI3K/AKTmTOR signaling pathway. | 2021 Dec |
1 |
| 3 |
34790723 | Berberine attenuates atherosclerotic lesions and hepatic steatosis in ApoE-/- mice by down-regulating PCSK9 via ERK1/2 pathway. | 2021 Oct |
2 |
| 4 |
31895879 | Berberine Attenuates Cholesterol Accumulation in Macrophage Foam Cells by Suppressing AP-1 Activity and Activation of the Nrf2/HO-1 Pathway. | 2020 Jan |
1 |
| 5 |
32231564 | Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE-/- Mice. | 2020 |
1 |
| 6 |
32566106 | Improvement of Endothelial Dysfunction of Berberine in Atherosclerotic Mice and Mechanism Exploring through TMT-Based Proteomics. | 2020 |
1 |
| 7 |
33088695 | Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe (-/-) mice. | 2020 Sep |
2 |
| 8 |
29202334 | Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe-/- mice. | 2018 Jan |
1 |
| 9 |
29393413 | Suppressive effects of berberine on atherosclerosis via downregulating visfatin expression and attenuating visfatin-induced endothelial dysfunction. | 2018 Apr |
1 |
| 10 |
30257374 | Berberine treatment reduces atherosclerosis by mediating gut microbiota in apoE-/- mice. | 2018 Nov |
1 |
| 11 |
29075339 | Berberine ameliorates non-alcoholic steatohepatitis in ApoE-/- mice. | 2017 Nov |
1 |
| 12 |
27181586 | Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe-/- mice with hyperhomocysteinemia. | 2016 Nov |
2 |
| 13 |
26177349 | Berberine via suppression of transient receptor potential vanilloid 4 channel improves vascular stiffness in mice. | 2015 Nov |
2 |
| 14 |
25425200 | Berberine derivatives reduce atherosclerotic plaque size and vulnerability in apoE(-/-) mice. | 2014 Nov 26 |
1 |
| 15 |
21980456 | Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. | 2011 |
1 |
| 16 |
19014947 | Berberine, a natural lipid-lowering drug, exerts prothrombotic effects on vascular cells. | 2009 Feb |
1 |